Cerevel Therapeutics Holdings Inc (CERE)
40.78
+0.14
(+0.34%)
USD |
NASDAQ |
May 31, 16:00
40.74
-0.04
(-0.10%)
After-Hours: 20:00
Cerevel Therapeutics Holdings Accounts Payable (Quarterly): 10.84M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.84M |
| December 31, 2023 | 11.86M |
| September 30, 2023 | 11.54M |
| June 30, 2023 | 9.389M |
| March 31, 2023 | 7.315M |
| December 31, 2022 | 10.06M |
| September 30, 2022 | 14.97M |
| June 30, 2022 | 11.01M |
| Date | Value |
|---|---|
| March 31, 2022 | 8.183M |
| December 31, 2021 | 11.30M |
| September 30, 2021 | 5.445M |
| June 30, 2021 | 4.986M |
| March 31, 2021 | 7.755M |
| December 31, 2020 | 4.993M |
| September 30, 2020 | 0.1518M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.1518M
Minimum
Sep 2020
14.97M
Maximum
Sep 2022
8.653M
Average
9.389M
Median
Jun 2023
Accounts Payable (Quarterly) Benchmarks
| AbbVie Inc | -- |
| Bristol-Myers Squibb Co | 3.539B |
| Madrigal Pharmaceuticals Inc | 21.53M |
| Viking Therapeutics Inc | 5.225M |
| Karuna Therapeutics Inc (DELISTED) | 6.783M |